🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical research study is to compare the confirmed com...
Status
Completed
Location
Molecular Md
Start Date
2007-09
Trial ID
NCT00481247
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
The suppression of the immune system creates a permissive environment for d...
Status
Unknown
Location
Multiple Locations
Start Date
2017-08-05
Trial ID
NCT03214718
Open-labeled, multicenter, phase I/II study of imatinib combined with ESHAP...
Status
Unknown
Location
Dong-A University Hospital
Start Date
2015-02
Trial ID
NCT02431403
Treatments Being Tested
To characterize pharmacokinetic profile of test product compared to that of...
Status
Completed
Location
Kailash Cancer Hospital & Research Centre
Start Date
2014-02
Trial ID
NCT02103322
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
Flinders Medical Centre
Start Date
2004-12
Trial ID
NCT00103168
Treatments Being Tested
The investigators hypothesize that, in newly diagnosed de novo chronic phas...
Status
Active Not Recruiting
Location
Chu Amiens Picardie
Start Date
2019-11-13
Trial ID
NCT04070443
This study will investigate the efficacy and tolerability of a short (6 mon...
Status
Unknown
Location
Medical University Innsbruck
Start Date
2004-01
Trial ID
NCT00327262
Treatments Being Tested
The goal of this clinical research is to learn if treatment with high-dose ...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-03
Trial ID
NCT01003054
Treatments Being Tested
Following the ACOSOG Z9001trial, imatinib received market authorization in ...
Status
Unknown
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02576080
Treatments Being Tested